| 2026-08-21 17:15 |
8-K |
["1.02", "9.01"] |
other |
0.05
|
Termination of failed business combination agreement with Nuclea Energy due to insufficient PIPE financing. |
SEC · detail |
| 2026-08-04 16:05 |
8-K |
["8.01", "9.01"] |
merger agreement |
0.85
|
8-K references recently announced business combination agreement with Nuclea Energy Inc., indicating M&A transaction in progress. |
SEC · detail |
| 2026-07-30 07:00 |
8-K |
["1.01"] |
merger agreement |
0.98
|
Definitive Business Combination Agreement between Mangoceuticals and Nuclea Energy announced via 8-K Item 1.01. |
SEC · detail |
| 2026-07-02 16:30 |
8-K |
["1.01", "3.02", "9.01"] |
other |
0.05
|
Private placement of common stock; no M&A indicators present. |
SEC · detail |